Eli Lilly and Company (LLY)
-NYSE 55.02 
0.88(1.57%) 04:00 SGT|After Hours
:
55.02 0.00 (0.00%) 06:09 SGT
| Prev Close: | 55.90 |
|---|
| Open: | 55.90 |
|---|
| Bid: | 54.83 x 200 |
|---|
| Ask: | 55.28 x 200 |
|---|
| 1y Target Est: | 56.41 |
|---|
| Beta: | 0.42 |
|---|
| Next Earnings Date: | 24-Jul-13 |
|---|
| Day's Range: | 54.88 - 55.94 |
|---|
| 52wk Range: | 39.93 - 58.40 |
|---|
| Volume: | 4,242,518 |
|---|
| Avg Vol (3m): | 5,128,520 |
|---|
| Market Cap: | 59.65B |
|---|
| P/E (ttm): | 13.22 |
|---|
| EPS (ttm): | 4.16 |
|---|
| Div & Yield: | 1.96 (3.50%) |
|---|
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Eli Lilly ends development of lymphoma drugAP(Sat, 11 May)
- State pharmacy boards back more FDA oversightAP(Fri, 10 May)
- Bashful men can buy the little blue pill onlineAP(Tue, 7 May)
- Eli Lilly: CEO Lechleiter will have aorta surgeryAP(Tue, 7 May)
- Bashful? Buy the little blue pill onlineAP(Tue, 7 May)
- Veeva Systems planning initial public offering: sourcesReuters(Wed, 1 May)
- Weak earnings prospects weigh on stocksAP(Thu, 25 Apr)
- P&G, AT&T drop after earnings, holding back DowAP(Thu, 25 Apr)
- Market tone remains positive on solid US earningsAP(Wed, 24 Apr)
- Asia stocks up on US company earns, home salesAP(Wed, 24 Apr)
Key Statistics
| Forward P/E (1 yr): | 20.15 |
|---|
| P/S (ttm): | 2.68 |
|---|
| Ex-Dividend Date: | 14-May-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 3.91 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 1.00 |
|---|
| Mean Recommendation*: | 2.6 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products worldwide. The companys neuroscience products treat major depressive disorders; schizophrenia, acute mixed or manic episodes associated with bipolar I...
View More